Updated May 2026 · SEC EDGAR data
How Did Bio-Techne Corporation (TECH) Perform?
Bio-Techne Corporation (TECH) is currently classified NEUTRAL on the EarningsCallAI operator signal, with HIGH confidence, drawn from 8 quarters of SEC EDGAR XBRL filings and earnings call commentary. Latest reported revenue is $311.4M. Revenue grew +4.8% year-over-year. EPS came in at $0.32, with net income of $51.0M. Sector: Healthcare.
Headline Numbers
What the NEUTRAL Signal Means
Bio-Techne Corporation is currently classified NEUTRAL with high confidence. Recent quarters are roughly flat with no decisive trend in either direction; management commentary is steady-state. This is "business as usual" with no major up or down signal for operators in the same market.
Revenue Trajectory
Bio-Techne Corporation grew revenue +4.8% year-over-year. Growth in this range is roughly in line with broader nominal economic growth, healthy but not exceptional. Most mature large-caps cluster here in steady-state quarters.
Net income of $51.0M on $311.4M of revenue translates to a 16.4 percent net margin, healthy by S&P 500 standards. The company is converting top-line growth into bottom-line profit at a meaningful rate.
Quarterly Profile
| Metric | Value |
|---|---|
| Operator Signal | NEUTRAL |
| Signal Confidence | HIGH |
| Sector | Healthcare |
| Quarters Tracked | 8 |
How the Signal Is Calculated
The EarningsCallAI operator signal blends a quantitative read of revenue trajectory across the most recent four to eight quarters with a qualitative read of management commentary in the earnings call. Both inputs come from primary public sources: SEC EDGAR XBRL filings for structured financials, and SEC Form 8-K earnings releases for management commentary. Where the two inputs agree, signal confidence is HIGH; where they conflict, confidence drops. Read the full methodology for the formal classification rules.
Frequently Asked Questions
How did Bio-Techne Corporation perform in its latest earnings report?
Bio-Techne Corporation reported $311.4M in revenue and $0.32 EPS in the most recent quarter filed on SEC EDGAR. Year-over-year revenue growth was +4.8%. The current operator signal is NEUTRAL with HIGH confidence.
What does Bio-Techne Corporation's NEUTRAL signal mean?
NEUTRAL means recent results are roughly flat with no decisive direction. The business is in steady state.
Where does Bio-Techne Corporation's data come from?
All structured financials, revenue, EPS, net income, growth rates, are pulled directly from Bio-Techne Corporation's SEC EDGAR XBRL filings (10-K, 10-Q). Operator signal classification is EarningsCallAI methodology, applied consistently across all S&P 500 companies and updated each earnings season. EDGAR data is in the public domain.
What sector is Bio-Techne Corporation in?
Bio-Techne Corporation is classified in the Healthcare sector. The classification follows standard S&P 500 sector taxonomy. To see how Bio-Techne Corporation compares to other companies in the same sector, browse the sector page or use the side-by-side comparison tool.
Is the NEUTRAL signal investment advice?
No. The operator signal is built for business operators evaluating market demand and competitive trends, not for stock trading decisions. A TAILWIND signal does not mean buy the stock; a HEADWIND signal does not mean sell. Always consult a licensed financial advisor before making investment decisions.
Bio-Techne Corporation (TECH) is currently classified NEUTRAL on the EarningsCallAI operator signal, with HIGH confidence, drawn from 8 quarters of SEC EDGAR XBRL filings and earnings call commentary. Latest reported revenue is $311.4M. Revenue grew +4.8% year-over-year. EPS came in at $0.32, with net income of $51.0M. Sector: Healthcare.